April 16, 2015 – Julie Deveso and Melissa Mroziak's friendship led them to join the Golden Retriever Lifetime Study together as a way to honor their loved ones lost to cancer.
Researchers will evaluate the safety and efficacy of a novel combination of checkpoint inhibitor and adoptive T-cell therapy in giant-breed dogs diagnosed with appendicular osteosarcoma, a type of primary bone cancer of the limbs.
Updated September 23, 2025 — Pet vaccines protect against deadly diseases, but understanding benefits, risks, and research can help you decide what’s best for your dog or cat.
June 29, 2023 — Morris Animal Foundation to offer new fellowship in honor of a world-renowned veterinary oncologist and the original principal investigator of the Golden Retriever Lifetime Study, Rodney Page
Updated May 19, 2026 — Histiocytic sarcoma is a rare, but deadly, cancer affecting dogs. Understanding the basics of this cancer is important for all dog owners!
April 16, 2025 — Morris Animal Foundation announces funding for four innovative research projects to improve care and treatment for dogs with osteosarcoma, the most common canine bone cancer.
Researchers will investigate the role of a genetic mutation found in about one third of dogs diagnosed with hemangiosarcoma, in an effort to find new therapies for dogs affected by this aggressive and highly metastatic cancer.
May 4, 2023 — Morris Animal Foundation has supported dog health studies for 75 years, including breakthroughs for parvovirus, eye diseases, heart health, seizures, pain management and cancer.